PRIMARY HYPERCHOLESTEROLEMIA OR MIXED HYPERLIPIDEMIA
Clinical trials for PRIMARY HYPERCHOLESTEROLEMIA OR MIXED HYPERLIPIDEMIA explained in plain language.
Never miss a new study
Get alerted when new PRIMARY HYPERCHOLESTEROLEMIA OR MIXED HYPERLIPIDEMIA trials appear
Sign up with your email to follow new studies for PRIMARY HYPERCHOLESTEROLEMIA OR MIXED HYPERLIPIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot could help millions with stubborn high cholesterol
Disease control Not yet recruitingThis study tests a new injectable drug called QLC7401 for people with high cholesterol that remains high even with standard treatments. About 780 adults will receive either the drug or a placebo to see if it safely lowers their LDL (bad) cholesterol. The goal is to provide an add…
Matched conditions: PRIMARY HYPERCHOLESTEROLEMIA OR MIXED HYPERLIPIDEMIA
Phase: PHASE3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 10:43 UTC
-
New shot could help control stubborn high cholesterol
Disease control Not yet recruitingThis study tests a new medicine called QLC7401 in adults with high cholesterol or mixed dyslipidemia who are not on other cholesterol drugs. About 510 participants will get either the study drug or a placebo as a shot under the skin. The main goal is to see how much it lowers "ba…
Matched conditions: PRIMARY HYPERCHOLESTEROLEMIA OR MIXED HYPERLIPIDEMIA
Phase: PHASE3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 10:38 UTC